De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
Launched by UNIVERSITY OF MICHIGAN · Apr 11, 2025
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on reducing unnecessary medical tests for patients preparing for certain low-risk surgeries, specifically breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair. The researchers want to see if a combination of strategies, like educating doctors, providing helpful decision-making tools, and giving feedback on test usage, can successfully lower the number of unnecessary tests performed before these surgeries. The goal is to make the process more efficient and safe for patients by ensuring that only necessary tests are conducted.
To participate in this trial, you need to be over 18 years old and your surgical center must have a high rate of unnecessary testing for one of the three procedures mentioned. There aren’t any other specific exclusion criteria, so if you meet the age requirement and your center qualifies, you might be eligible. Participants can expect to be involved in a system that aims to improve care by reducing unnecessary procedures, which could lead to a smoother surgical experience. The trial is currently recruiting participants, and it’s open to individuals of all genders.
Gender
ALL
Eligibility criteria
- • Site
- Inclusion Criteria:
- • Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair)
- Exclusion Criteria:
- • none
- • Surgical participants must be over 18 years old.
About University Of Michigan
The University of Michigan, a leading academic institution renowned for its commitment to advancing healthcare and medical research, serves as a prominent clinical trial sponsor. With a robust infrastructure that supports innovative research initiatives, the university leverages its multidisciplinary expertise to conduct a wide array of clinical trials aimed at improving patient outcomes and advancing medical knowledge. Through its state-of-the-art facilities and collaborative environment, the University of Michigan fosters partnerships between researchers, clinicians, and industry leaders, ensuring the development of cutting-edge therapies and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Lesly Dossett, MD, MPH
Principal Investigator
University of Michigan
Hari Nathan, PhD
Principal Investigator
University of Michigan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported